A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or Obesity
NCT06718998
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
134
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
NNC0519-0130
Sponsor
Novo Nordisk A/S